Drugs for GIST (Gastrointestinal Stromal Tumor)
Here are the drugs and financial support services available to patients receiving treatment for GIST (Gastrointestinal Stromal Tumor).
Gleevec (imatinib mesylate) Tablets
Drug company: Novartis
Gleevec is a kinase inhibitor used for the treatment of patients with Kit (CD117)-positive unresectable, recurrent and/or metastatic gastrointestinal stromal tumor (GIST), and as an adjuvant treatment.
Novartis’ Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using Gleevec:
Gleevec Patient Support Program
This program offers patient counselors, educational information, and financial assistance resources, such as the Gleevec $10 Co-Pay Card.
Gleevec $10 Co-Pay Card
Patients with private insurance may pay only $10 for a 30-day supply of Gleevec, with a maximum of $10,630 for a 30-day supply and up to an annual maximum of $30,000.
Novartis Patient Assistance Foundation
Patients who are experiencing financial hardship and have limited or no public or private prescription coverage may be able to receive Gleevec for free through the Novartis Patient Assistance Foundation. To be eligible for financial assistance, the patient must be a US citizen and must provide proof of income that meets the financial eligibility requirements. Eligible patients may receive Gleevec for free until a prescription drug coverage becomes available to them.
Stivarga (regorafenib) Tablets
Drug company: Bayer
Stivarga is a kinase inhibitor used for the treatment of patients with locally advanced, unresectable or metastatic GIST.
Bayer offers 2 financial assistance programs for patients using Stivarga:
STIVARGA $0 Co-Pay Program
Through this program, patients with private insurance will have a $0 copay for Stivarga, up to $25,000 per patient annually.
REACH Patient Assistance Program
Uninsured or underinsured patients who are prescribed Stivarga should contact the Resources for Expert Assistance and Care Helpline (REACH) services counselor to possibly qualify for free medication.
Sutent (sunitinib malate) Capsule
Drug company: Pfizer
Sutent is a kinase inhibitor used for the treatment of patients with GIST.
Pfizer Oncology Together offers 2 financial assistance programs for patients using Sutent:
Pfizer Oncology Together Co-Pay Savings Program
This Pfizer program assists eligible patients with private insurance so that their copay for Sutent is $0 monthly, with a maximum savings of up to $25,000 annually.
Pfizer Patient Assistance Program
This program serves patients who are either uninsured or those with government insurance. Uninsured patients may qualify to receive Sutent for free or at a savings. Eligible patients with government insurance who cannot find independent charitable foundation support may receive Sutent for free.
Table. Drugs Prescribed for GIST (Gastrointestinal Stromal Tumor)
- Drug name (generic name)
- Drug company
- Patient support services
Last modified: March 7, 2019